Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Prognostic factors in infective endocarditis in general hospitals in the Netherlands.

van den Brink F, Hasenaar J, Winia V, Klomp M, Van Vlies B, Nicastia D, Groenmeijer B, Braam R, Jaarsma W, Funke Kupper AJ.

Neth Heart J. 2016 Dec;24(12):717-721.

2.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

3.

Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.

Boriani G, Manolis AS, Tukkie R, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, Gulizia M, Samoilenko IV, Wolff C, Holbrook R, Gavazza F, Padeletti L; MINERVA Investigators.

Heart Rhythm. 2015 Jun;12(6):1192-200. doi: 10.1016/j.hrthm.2015.02.017. Epub 2015 Feb 19.

PMID:
25701774
4.

Treatment of anemia with darbepoetin alfa in systolic heart failure.

Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators.

N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10.

5.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED-HF Committees Investigators.

Eur J Heart Fail. 2013 Mar;15(3):334-41. doi: 10.1093/eurjhf/hfs204. Epub 2013 Jan 17.

6.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

7.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators.

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.

8.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
9.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators.

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
10.

[Prevention of perioperative cardiac complications in non-cardiac surgery: an evidence-based guideline].

Damen J, Hagemeijer JW, van den Broek L, Poldermans D; CBO-werkgroep Preventie Perioperatieve Cardiale Complicaties bij Niet-cardiale Chirurgie.

Ned Tijdschr Geneeskd. 2008 Nov 29;152(48):2612-6. Dutch.

PMID:
19102436
11.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
13.

Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.

Somsen GA, van der Wall EE, van Vlies B, Borm JJ, van Royen EA.

Int J Card Imaging. 1996 Dec;12(4):305-10.

PMID:
8993993
14.

Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Somsen GA, van Vlies B, de Milliano PA, Borm JJ, van Royen EA, Endert E, Lie KI.

Heart. 1996 Sep;76(3):218-22.

15.

Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference.

Somsen GA, Borm JJ, de Milliano PA, van Vlies B, Dubois EA, van Royen EA.

Eur J Nucl Med. 1995 Oct;22(10):1149-54.

PMID:
8542899
16.

Exclusion of acute myocardial infarction. The value of measuring creatine kinase slope.

Bakker AJ, Koelemay MJ, van Vlies B, Gorgels JP, Smits R, Tijssen JG, Haagen FD.

Eur J Clin Chem Clin Biochem. 1995 Jun;33(6):351-63.

PMID:
7578616
17.

Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy.

Valdés Olmos RA, ten Bokkel Huinink WW, ten Hoeve RF, van Tinteren H, Bruning PF, van Vlies B, Hoefnagel CA.

Eur J Cancer. 1995;31A(1):26-31.

PMID:
7695974
18.

Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction.

Valdés Olmos RA, ten Bokkel Huinink WW, ten Hoeve RF, van Tinteren H, Bruning PF, van Vlies B, Hoefnagel CA.

Ann Oncol. 1994 Sep;5(7):617-22.

PMID:
7993837
19.

Contribution of creatine kinase MB mass concentration at admission to early diagnosis of acute myocardial infarction.

Bakker AJ, Gorgels JP, van Vlies B, Koelemay MJ, Smits R, Tijssen JG, Haagen FD.

Br Heart J. 1994 Aug;72(2):112-8.

20.

Troponin T and myoglobin at admission: value of early diagnosis of acute myocardial infarction.

Bakker AJ, Koelemay MJ, Gorgels JP, van Vlies B, Smits R, Tijssen JG, Haagen FD.

Eur Heart J. 1994 Jan;15(1):45-53.

PMID:
8174583

Supplemental Content

Loading ...
Support Center